Globus Medical - Public Comps and Valuation Multiples

Globus Medical Overview

About Globus Medical

Globus Medical Inc is a medical device company that develops and provides healthcare products and solutions to hospitals, physicians, and surgical centers. The firm's products are organized into two categories: musculoskeletal solutions, which include medical devices and instruments used mostly for spinal and orthopedic procedures, and enabling technologies, which include computer systems developed for enhancing surgical capabilities. The vast majority of the company's revenue is generated from musculoskeletal solutions products, and more than half of the revenue is earned in the United States. It also has its presence internationally.

Founded

2003

HQ

Employees

5.3K+

Website

globusmedical.com

Sectors

Medical Devices
DeepTech
HealthTech

Financials

LTM Revenue $2.8B

LTM EBITDA $784M

EV

$7.8B

Valuation Multiples

Multiples.vc

Valuation Multiples for 15K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Browse Valuation Multiples

Globus Medical Financials

As of August 2025, Globus Medical reported last 12-month revenue of $2.8B and EBITDA of $784M.

In the same period, Globus Medical generated $1.8B in LTM gross profit and $440M in net income.

See Globus Medical valuation multiples based on analyst estimates

Globus Medical P&L

In the most recent fiscal year, Globus Medical reported revenue of $2.5B and EBITDA of $474M.

Globus Medical expects next 12-month revenue of XXX and NTM EBITDA of XXX

See Globus Medical valuation multiples based on analyst estimates

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Revenue	$2.8B	XXX	$2.5B	XXX	XXX	XXX
Gross Profit	$1.8B	XXX	$1.5B	XXX	XXX	XXX
Gross Margin	67%	XXX	59%	XXX	XXX	XXX
EBITDA	$784M	XXX	$474M	XXX	XXX	XXX
EBITDA Margin	28%	XXX	19%	XXX	XXX	XXX
EBIT	$582M	XXX	$220M	XXX	XXX	XXX
EBIT Margin	21%	XXX	9%	XXX	XXX	XXX
Net Profit	$440M	XXX	$103M	XXX	XXX	XXX
Net Margin	16%	XXX	4%	XXX	XXX	XXX
Net Debt	XXX	XXX	n/a	XXX	XXX	XXX

Financial data powered by Morningstar, Inc.

.seo-only-financials-wrapper { position: static; left: auto; width: auto; height: auto; overflow: visible; }

Financial performance metrics for Globus Medical including revenue, profitability, and margin analysis across different time periods. The company reported last twelve months revenue of $2.8B. EBITDA for the last twelve months was $784M. In the most recent fiscal year, Globus Medical achieved $2.5B in revenue and $474M in EBITDA.
Financial Metric	Last Twelve Months (LTM)	Next Twelve Months (NTM)	Most Recent Fiscal Year	Current Fiscal Year (2025)	Next Fiscal Year (2026)	Two Years Forward (2027)
Total Revenue	$2.8B	Analyst estimates available to subscribers	$2.5B	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Gross Profit	$1.8B	Analyst estimates available to subscribers	$1.5B	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Gross Profit Margin	66.6% gross margin	Analyst estimates available to subscribers	58.9% gross profit margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBITDA (Earnings Before Interest, Taxes, Depreciation, Amortization)	$784M	Analyst estimates available to subscribers	$474M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBITDA Margin	28.4% EBITDA margin	Analyst estimates available to subscribers	18.8% EBITDA margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBIT (Earnings Before Interest and Taxes)	$582M	Analyst estimates available to subscribers	$220M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBIT Margin	21.1% EBIT margin	Analyst estimates available to subscribers	8.7% EBIT margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Income (Net Profit)	$440M	Analyst estimates available to subscribers	$103M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Profit Margin	16.0% net profit margin	Analyst estimates available to subscribers	4.1% net profit margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Debt Position	Detailed debt information available to subscribers	Detailed debt information available to subscribers	n/a	Detailed debt information available to subscribers	Detailed debt information available to subscribers	Detailed debt information available to subscribers

Financial Performance Summary for Globus Medical

This financial data table provides comprehensive performance metrics for Globus Medical, a company based in United States of America. The metrics include revenue, profitability measures, and operational efficiency indicators across multiple time periods.

Recent Performance Highlights

Globus Medical generated $2.8B in revenue over the last twelve months.
The company achieved $784M in EBITDA over the last twelve months.
Gross profit for the last twelve months was $1.8B.
Net income over the last twelve months reached $440M.

Fiscal Year Performance

In the most recent fiscal year, Globus Medical reported $2.5B in total revenue.
Fiscal year EBITDA was $474M.
The company maintained a gross profit margin of 58.9% in the most recent fiscal year.
EBITDA margin for the fiscal year was 18.8%.
Net profit margin reached 4.1% in the most recent fiscal year.

This financial data is sourced from Morningstar, Inc. and represents the most recent available information for Globus Medical. Forward-looking estimates and detailed financial projections are available through our premium subscription service.

Globus Medical Stock Performance

Globus Medical has current market cap of $7.9B, and EV of $7.8B.

Market Cap Evolution

Globus Medical Stock Data

As of September 12, 2025, Globus Medical's stock price is $59.

See Globus Medical trading valuation data

EV	Market Cap	Price 1D	Price 1M	Price 3M	Price 12M	EPS
$7.8B	$7.9B	XXX	XXX	XXX	XXX	$3.19

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Start Free Trial

Globus Medical Valuation Multiples

Globus Medical's trades at 3.1x EV/Revenue multiple, and 16.5x EV/EBITDA.

See valuation multiples for Globus Medical and 15K+ public comps

Globus Medical Financial Valuation Multiples

As of September 12, 2025, Globus Medical has market cap of $7.9B and EV of $7.8B.

Equity research analysts estimate Globus Medical's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

Globus Medical has a P/E ratio of 18.0x.

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Market cap (current)	$7.9B	XXX	$7.9B	XXX	XXX	XXX
EV (current)	$7.8B	XXX	$7.8B	XXX	XXX	XXX
EV/Revenue	2.8x	XXX	3.1x	XXX	XXX	XXX
EV/EBITDA	10.0x	XXX	16.5x	XXX	XXX	XXX
EV/EBIT	13.4x	XXX	35.6x	XXX	XXX	XXX
EV/Gross Profit	4.3x	XXX	n/a	XXX	XXX	XXX
P/E	18.0x	XXX	77.0x	XXX	XXX	XXX
EV/FCF	40.8x	XXX	19.3x	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get Globus Medical Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Start Free Trial

Globus Medical Margins & Growth Rates

Globus Medical's last 12 month revenue growth is 9%

Globus Medical's revenue per employee in the last FY averaged $0.5M, while opex per employee averaged $0.2M for the same period.

Globus Medical's rule of 40 is 31% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Globus Medical's rule of X is 51% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

See operational valuation multiples for Globus Medical and other 15K+ public comps

Globus Medical Operational Valuation Multiples

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Revenue Growth	9%	XXX	10%	XXX	XXX	XXX
EBITDA Margin	28%	XXX	19%	XXX	XXX	XXX
EBITDA Growth	11%	XXX	52%	XXX	XXX	XXX
Rule of 40	31%	XXX	28%	XXX	XXX	XXX
Bessemer Rule of X	XXX	XXX	51%	XXX	XXX	XXX
Revenue per Employee	XXX	XXX	$0.5M	XXX	XXX	XXX
Opex per Employee	XXX	XXX	$0.2M	XXX	XXX	XXX
S&M Expenses to Revenue	XXX	XXX	n/a	XXX	XXX	XXX
G&A Expenses to Revenue	XXX	XXX	n/a	XXX	XXX	XXX
R&D Expenses to Revenue	XXX	XXX	6%	XXX	XXX	XXX
Opex to Revenue	XXX	XXX	50%	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics

Pharma Analytics

Private Equity

ERP Software

Developer Tools

Consumer SaaS

Streaming Platforms

Explore Valuation Multiples by Industry

Start Free Trial